The trading price of Unitedhealth Group Inc (NYSE:UNH) closed lower on Friday, May 23, and closing at $293.42, -0.73% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $289.13 and $299.95. The company’s P/E ratio in the trailing 12-month period was 12.27, while its 5Y monthly beta was 0.571. In examining the 52-week price action we see that the stock hit a 52-week high of $630.73 and a 52-week low of $248.88. Over the past month, the stock has lost -29.91% in value.
Unitedhealth Group Inc, whose market valuation is $266.18 billion at the time of this writing, is expected to release its quarterly earnings report on 2025-Apr-16. The dividend yield on the company stock is 2.86%, while its Forward Dividend ratio is 8.40. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 5.07 per share this quarter, however they have predicted annual earnings per share of 22.85 for current year and 26.75 for next year.
Analysts have forecast the company to bring in revenue of 111.93B for the current quarter, with the likely lows of 110.09B and highs of 115.54B. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 450.41B.
On the technical side, indicators suggest UNH has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned UNH a recommendation rating is 28. Out of them, 2 rate it a Hold, while 23 recommend Buy, whereas 1 assign an Overweight rating. 0 analyst(s) have tagged Unitedhealth Group Inc (UNH) as Underweight, while 2 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 5.03, which symbolizes a positive outlook. A quick review shows that UNH’s price is currently -15.78% off the SMA20 and -34.27% off the SMA50. The RSI metric on the 14-day chart is currently showing 26.74, and weekly volatility stands at 3.28%. When measured over the past 30 days, the indicator reaches 5.75%. Unitedhealth Group Inc (NYSE:UNH)’s beta value is currently sitting at 0.49, while the Average True Range indicator is currently displaying 19.54. With analysts defining $270-$635 as the low and high price targets, we arrive at a consensus price target of $367 for the trailing 12-month period. The current price is about 7.98% off the estimated low and -116.41% off the forecast high, based on this estimate. Investors will be thrilled if UNH’s share price rises to $367, which is the median consensus price. At that level, UNH’s share price would be -25.08% below current price.
To see how Unitedhealth Group Inc stock has been performing in comparison to its peers in the industry, here are the numbers: UNH stock’s performance was -0.73% in the latest trading, and -43.72% in the past year. Unitedhealth Group Inc has a P/E ratio of 12.27.
An evaluation of the daily trading volume of Unitedhealth Group Inc (NYSE:UNH) indicates that the 3-month average is 13.54 million. However, this figure has increased over the past 10 days to an average of 49.7.
Currently, records show that 910.00 million of the company’s shares remain outstanding. The insiders hold 0.24% of outstanding shares, whereas institutions hold 91.28%. The stats also highlight that short interest as of 2025-04-30, stood at 8.85 million shares, resulting in a short ratio of 1.03 at that time. From this, we can conclude that short interest is 98.00 of the company’s total outstanding shares. It is noteworthy that short shares in April were down slightly from the previous month’s figure, which was 10.87 million. However, since the stock’s price has seen -41.99% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
